40780_2018_128_MOESM3_ESM.xls (18.5 kB)
Additional file 3: of Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)
dataset
posted on 2018-12-10, 05:00 authored by Hisanori Shimizu, Kenichi Suzuki, Takeshi Uchikura, Daiki Tsuji, Takeharu Yamanaka, Hironobu Hashimoto, Koichi Goto, Reiko Matsui, Nobuhiko Seki, Toshikazu Shimada, Shunya Ikeda, Naoki Ikegami, Toshihiro Hama, Nobuyuki Yamamoto, Tadanori SasakiTable S2. Drug cost of antiemetics on the National Health Insurance drug price standard in 2017. (XLS 18 kb)
